{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:41:58Z","timestamp":1785584518202,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017954","name":"Fujian Provincial Department of Finance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017357","name":"Science and Technology Projects of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.conctc.2024.101339","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:36:45Z","timestamp":1722145005000},"page":"101339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-8689","authenticated-orcid":false,"given":"Yingzhe","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-494X","authenticated-orcid":false,"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-2486","authenticated-orcid":false,"given":"Peilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1928-3624","authenticated-orcid":false,"given":"Jiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9511-6986","authenticated-orcid":false,"given":"Xiaodong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2024.101339_bib1","series-title":"World Alzheimer Report","year":"2021"},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimer's Dementia : the journal of the Alzheimer's Association"},{"key":"10.1016\/j.conctc.2024.101339_bib3","article-title":"Cognitive symptoms of Alzheimer's disease: clinical management and prevention","volume":"367","author":"Joe","year":"2019","journal-title":"Br. Med. J."},{"issue":"11","key":"10.1016\/j.conctc.2024.101339_bib4","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.conctc.2024.101339_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fphar.2018.00548","article-title":"Anti-neuroinflammatory potential of natural Products in attenuation of Alzheimer's disease","volume":"9","author":"Shal","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.conctc.2024.101339_bib6","article-title":"Chinese medicinal Herbs in the treatment of diabetic cognitive impairment: a systematic review and meta-analysis","volume":"2018","author":"Yan","year":"2018","journal-title":"Evid. base Compl. Alternative Med. : eCAM."},{"issue":"9","key":"10.1016\/j.conctc.2024.101339_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/ptr.5188","article-title":"Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)","volume":"28","author":"Fu","year":"2014","journal-title":"Phytother Res. : PT"},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib8","first-page":"49","article-title":"Clinical study on Huangqi Yinao in the treatment of Alzheimer's disease in the elderly","author":"Ma","year":"2008","journal-title":"Journal of Mathematical Medicine"},{"issue":"6","key":"10.1016\/j.conctc.2024.101339_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.14336\/AD.2017.0816","article-title":"Anti-aging Implications of Astragalus membranaceus (Huangqi): a well-known Chinese tonic","volume":"8","author":"Liu","year":"2017","journal-title":"Aging and disease"},{"key":"10.1016\/j.conctc.2024.101339_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113293","article-title":"Astragalus species: phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases","volume":"202","author":"Abd Elrahim Abd Elkader","year":"2022","journal-title":"Phytochemistry"},{"issue":"6","key":"10.1016\/j.conctc.2024.101339_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1139\/apnm-2017-0585","article-title":"Dietary supplementation with Allium hirtifolium and\/or Astragalus hamosus improved memory and reduced neuro-inflammation in the rat model of Alzheimer's disease","volume":"43","author":"Bahaeddin","year":"2018","journal-title":"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme"},{"key":"10.1016\/j.conctc.2024.101339_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147041","article-title":"Astragaloside IV prevents A\u03b2(1-42) oligomers-induced memory impairment and hippocampal cell apoptosis by promoting PPAR\u03b3\/BDNF signaling pathway","volume":"1747","author":"Wang","year":"2020","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.conctc.2024.101339_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1248\/bpb.b21-00381","article-title":"Astragaloside IV Ameliorates cognitive impairment and neuroinflammation in an oligomeric A\u03b2 induced Alzheimer's disease Mouse model via inhibition of microglial activation and NADPH Oxidase expression","volume":"44","author":"Chen","year":"2021","journal-title":"Biol. Pharmaceut. Bull."},{"key":"10.1016\/j.conctc.2024.101339_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1020614","article-title":"Depichering the effects of astragaloside IV on AD-like Phenotypes: a systematic and experimental investigation","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.conctc.2024.101339_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098866","article-title":"Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.conctc.2024.101339_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ar.21386","article-title":"Protective effect of extract of Astragalus on learning and memory impairments and neurons' apoptosis induced by glucocorticoids in 12-month-old male mice","volume":"294","author":"Li","year":"2011","journal-title":"Anat. Rec."},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2020.07.122","article-title":"Astragalus polysaccharide alleviates cognitive impairment and \u03b2-amyloid accumulation in APP\/PS1 mice via Nrf2 pathway","volume":"531","author":"Qin","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.conctc.2024.101339_bib18","first-page":"18","article-title":"Astragalus membranaceus-polysaccharides Ameliorates obesity, hepatic Steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition in metabolically stressed APPswe\/PS1dE9 mice","author":"Huang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23041989","article-title":"Aging, cellular senescence, and Alzheimer's disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physrev.00026.2007","article-title":"Telomeres and aging","volume":"88","author":"Aubert","year":"2008","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.conctc.2024.101339_bib21","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1007\/s12035-023-03337-4","article-title":"Exploring the causal relationship between telomere biology and Alzheimer's disease","volume":"60","author":"Kuan","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.conctc.2024.101339_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13195-021-00871-y","article-title":"Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE \u03b54-carriers","volume":"13","author":"Hackenhaar","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-190759","article-title":"Telomere length and the risk of Alzheimer's disease: the Rotterdam study","volume":"73","author":"Fani","year":"2020","journal-title":"J. Alzheim. Dis. : JAD."},{"issue":"10","key":"10.1016\/j.conctc.2024.101339_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biology12101286","article-title":"The shortening of leukocyte telomere length Contributes to Alzheimer's disease: further evidence from late-onset familial and sporadic cases","volume":"12","author":"Crocco","year":"2023","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.conctc.2024.101339_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3892\/etm.2021.10761","article-title":"Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose-induced senescence and apoptosis","volume":"22","author":"Hong","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1474-9726.2011.00700.x","article-title":"The telomerase activator TA-65 elongates short telomeres and increases health span of adult\/old mice without increasing cancer incidence","volume":"10","author":"Bernardes de Jesus","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.conctc.2024.101339_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2022.06.230","article-title":"The role of cycloastragenol at the intersection of NRF2\/ARE, telomerase, and proteasome activity","volume":"188","author":"Yilmaz","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/18756190MTA4dNjE52","article-title":"The links between cardiovascular diseases and Alzheimer's disease","volume":"19","author":"Leszek","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jnr.23777","article-title":"Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease","volume":"95","author":"Daulatzai","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12935","article-title":"Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia","volume":"31","author":"Tayler","year":"2021","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.conctc.2024.101339_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1148\/radiol.12120928","article-title":"Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity","volume":"267","author":"Binnewijzend","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.conctc.2024.101339_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003103","article-title":"Hypotension with neurovascular changes and cognitive dysfunction: an epidemiological, pathobiological, and treatment review","author":"Cheng","year":"2024","journal-title":"Chin. Med. J."},{"issue":"1\u20132","key":"10.1016\/j.conctc.2024.101339_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.08.056","article-title":"Relationship between orthostatic hypotension and cognitive impairment in the elderly","volume":"299","author":"Mehrabian","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000247586","article-title":"High prevalence of orthostatic hypotension in mild dementia","volume":"28","author":"Sonnesyn","year":"2009","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"5","key":"10.1016\/j.conctc.2024.101339_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096656","article-title":"Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study","volume":"9","author":"Nicolini","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10072-021-05450-5","article-title":"Orthostatic hypotension in patients with Alzheimer's disease: a meta-analysis of prospective studies","volume":"43","author":"Isik","year":"2022","journal-title":"Neurol. Sci. : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/HYPERTENSIONAHA.121.17454","article-title":"From normal cognition to cognitive impairment and dementia: impact of orthostatic hypotension","volume":"78","author":"Xia","year":"2021","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.conctc.2024.101339_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002143","article-title":"Orthostatic hypotension and the long-term risk of dementia: a population-based study","volume":"13","author":"Wolters","year":"2016","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.conctc.2024.101339_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jgs.12592","article-title":"Cognitive performance in orthostatic hypotension: findings from a nationally representative sample","volume":"62","author":"Frewen","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.conctc.2024.101339_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.09.028","article-title":"Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment","volume":"382","author":"Bocti","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.conctc.2024.101339_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2019.112682","article-title":"Neurogenic orthostatic hypotension impairs information processing speed and attention","volume":"211","author":"Robinson","year":"2019","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.conctc.2024.101339_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1469-8986.2006.00472.x","article-title":"Enhancement of cerebral blood flow and cognitive performance following pharmacological blood pressure elevation in chronic hypotension","volume":"44","author":"Duschek","year":"2007","journal-title":"Psychophysiology"},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14586","article-title":"Aberrant microstructural integrity of white matter in mild and severe orthostatic hypotension: a NODDI study","volume":"30","author":"Cheng","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14712","article-title":"Brain white matter changes and their associations with non-motor dysfunction in orthostatic hypotension in \u03b1-synucleinopathy: a NODDI study","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14571","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.conctc.2024.101339_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.biopsycho.2007.03.007","article-title":"Dissociation between cortical activation and cognitive performance under pharmacological blood pressure elevation in chronic hypotension","volume":"75","author":"Duschek","year":"2007","journal-title":"Biol. Psychol."},{"issue":"8","key":"10.1016\/j.conctc.2024.101339_bib48","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2174\/1570159X20666220315163856","article-title":"Advances in the pharmacological and non-pharmacological management of non-motor symptoms in Parkinson's disease: an update since 2017","volume":"21","author":"Wamelen","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.conctc.2024.101339_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019604","article-title":"Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review","volume":"6","author":"Fu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.conctc.2024.101339_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115578","article-title":"Bidirectional effects and mechanisms of traditional Chinese medicine","volume":"298","author":"Peng","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.conctc.2024.101339_bib51","first-page":"293","article-title":"The research progress of traditional Chinese medicine in the treatment of orthostatic hypotension","volume":"21","author":"Zhang","year":"2023"},{"key":"10.1016\/j.conctc.2024.101339_bib52","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"Br. Med. J."},{"issue":"8","key":"10.1016\/j.conctc.2024.101339_bib53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(22)00169-7","article-title":"Diagnosis and treatment of orthostatic hypotension","volume":"21","author":"Wieling","year":"2022","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.conctc.2024.101339_bib54","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","article-title":"NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain","volume":"61","author":"Zhang","year":"2012","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00062-019-00805-0","article-title":"Microstructural white matter Alterations in mild cognitive impairment and Alzheimer's disease : study based on neurite orientation dispersion and density imaging (NODDI)","volume":"30","author":"Fu","year":"2020","journal-title":"Clin. Neuroradiol."},{"issue":"11","key":"10.1016\/j.conctc.2024.101339_bib56","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1538-7836.2011.04507.x","article-title":"External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?","volume":"9","author":"Beyer-Westendorf","year":"2011","journal-title":"J. Thromb. Haemostasis : JTH."},{"issue":"1\u20132","key":"10.1016\/j.conctc.2024.101339_bib57","first-page":"218","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy","volume":"144","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.conctc.2024.101339_bib58","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatr. : J. Ment. Sci."},{"issue":"7","key":"10.1016\/j.conctc.2024.101339_bib59","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","article-title":"Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-\/-): a double-blind, randomized, placebo-controlled crossover trial","volume":"39","author":"Xu","year":"2020","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000110111","article-title":"Multivariate analysis of Hachinski's Scale for discriminating senile dementia of the Alzheimer's Type from multiinfarct dementia","volume":"6","author":"Molgaard","year":"1987","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.conctc.2024.101339_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dementia : the journal of the Alzheimer's Association"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T17:51:29Z","timestamp":1726681889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"alternative-id":["S2451865424000863"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101339","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101339"}}